IGF1 and retinopathy of prematurity: A peak in the incidence of ROP in 2005–2006 and the very promising prognostic findings of the Early Treatment for ROP Trial (29), prompted us to begin an exhaustive study of the etiology of this disease, and to investigate the diagnostic relevance of IGF1 levels.